Inhibition of P53/miR‐34a improves diabetic endothelial dysfunction via activation of SIRT1

Endothelial dysfunction contributes to diabetic macrovascular complications, resulting in high mortality. Recent findings demonstrate a pathogenic role of P53 in endothelial dysfunction, encouraging the investigation of the effect of P53 inhibition on diabetic endothelial dysfunction. Thus, high glu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Junduo, Liang, Wenzhao, Tian, Yueli, Ma, Fuzhe, Huang, Wenlin, Jia, Ye, Jiang, Ziping, Wu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484332/
https://www.ncbi.nlm.nih.gov/pubmed/30793480
http://dx.doi.org/10.1111/jcmm.14253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484332/
https://www.ncbi.nlm.nih.gov/pubmed/30793480
http://dx.doi.org/10.1111/jcmm.14253

Ejemplares similares